Abstract
BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. The exact pathogenesis behind the development of MS is unknown. This study aims to elucidate the role of fibrinogen in MS pathology and discuss candidacy as a biomarker for disease management.
METHOD: The method applied is a systematic literature review on the bio-medical database PubMed.
RESULTS: This study found that even though the role of fibrinogen in disease development has been studied considerably, clinical application as a viable biomarker has not yet been achieved conclusively in human studies.
CONCLUSION: Recent evidence points toward fibrinogen and its degradation products playing a possible role in the disease pathogenesis Further research is needed to convincingly evaluate fibrinogen as a practical biomarker for diagnostic use or for assessing disease severity.
| Original language | English |
|---|---|
| Journal | Multiple Sclerosis and Related Disorders |
| Volume | 46 |
| Pages (from-to) | 102509 |
| ISSN | 2211-0348 |
| DOIs | |
| Publication status | Published - Nov 2020 |
Keywords
- Fibrinogen
- Fibrin
- Multiple sclerosis
- Blood
- Cerebrospinal fluid
- Diagnosis
- Therapeutic use
- Prognostic use
- Immunology
Fingerprint
Dive into the research topics of 'Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS